Can public access to genome sequencing help mitigate overall risk in the future of medicine? With broader availability, new services can help propel testing to new heights. Listen in to learn:

• Why someone may choose to test their genome sequencing
• Possible roadblocks in utilizing genetic testing
• The timeline in the future for Merogenomics Inc.

Dr. Mikolaj Raszek, founder and managing director of Merogenomics Inc., shares his work to bring public access to genetic testing.

Many folks are familiar with the genetic testing available to the public today, like those designed to examine ancestry and basic medical information. However, if more in-depth testing can be made available to the public, much more beneficial and meaningful data can be disseminated, mitigating significant risks to the patient.

If we can examine the genome of any one, we can determine the likelihood of thousands of conditions they may develop in the future. With this knowledge, they can choose to take risk-mitigating action much earlier, hopefully nipping the problem in the bud.

Visit https://merogenomics.ca to learn more.

Episode also available on Apple Podcast: http://apple.co/30PvU9C

Podcast: Play in new window | Download | Embed